Researcher.Life Logo

ERJ Open Research : Impact Factor & More

eISSN: 2312-0541pISSN: 2312-0541
JournalOpen Access

Key Metrics

CiteScore
4.6
Impact Factor
< 5
Scite Index
0.87 5-Year SI
SJR
Q2Pulmonary and Respiratory Medicine
SNIP
1.15
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on ERJ Open Research

ERJ Open Research Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher EUROPEAN RESPIRATORY SOC JOURNALS LTD
Language English
Frequency Quarterly
Article Processing ChargesEUR 750
Publication Time8
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorEuropean Respiratory Society
FrequencyQuarterly
Publication Start Year2015
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 8
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
License typeCC BY-NC
OA statementVisit website
View less

Planning to publish in ERJ Open Research ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in ERJ Open Research

Reply: Residual airways: the lingering legacy of severe respiratory syncytial virus bronchiolitis
  • 16 Feb 2026
  • ERJ Open Research
Prognostic biomarkers for idiopathic pulmonary fibrosis: findings from ISABELA clinical trials
  • 16 Feb 2026
  • ERJ Open Research
Former smokers with severe eosinophilic asthma respond to benralizumab as effectively as never-smokers: a post hoc analysis of the ANANKE study
  • 16 Feb 2026
  • ERJ Open Research
ERJ Open Research in 2026: progress and future directions
  • 16 Feb 2026
  • ERJ Open Research
Residual airways: the lingering legacy of severe respiratory syncytial virus bronchiolitis
  • 16 Feb 2026
  • ERJ Open Research
Rectifying COPD management: a critical analysis of the Global Initiative for Chronic Obstructive Lung Disease strategy
  • 16 Feb 2026
  • ERJ Open Research
Reply: Residual airways: the lingering legacy of severe respiratory syncytial virus bronchiolitis
  • 16 Feb 2026
  • ERJ Open Research
Prognostic biomarkers for idiopathic pulmonary fibrosis: findings from ISABELA clinical trials
  • 16 Feb 2026
  • ERJ Open Research
Former smokers with severe eosinophilic asthma respond to benralizumab as effectively as never-smokers: a post hoc analysis of the ANANKE study
  • 16 Feb 2026
  • ERJ Open Research
ERJ Open Research in 2026: progress and future directions
  • 16 Feb 2026
  • ERJ Open Research
Residual airways: the lingering legacy of severe respiratory syncytial virus bronchiolitis
  • 16 Feb 2026
  • ERJ Open Research
Rectifying COPD management: a critical analysis of the Global Initiative for Chronic Obstructive Lung Disease strategy
  • 16 Feb 2026
  • ERJ Open Research

FAQs on ERJ Open Research